Each dot is one of the 49 Healthcare IT stocks, sized by market cap. The median Revenue Growth (1y) (TTM) is 8.8% and the median P/E 27.95. Pinned to the edge: 2 outliers on X and 0 on Y.
Quadrants split at the medians. Hover a dot for its true values; click to open the company. Outliers are more than 3× the interquartile range beyond the quartiles.
| # | Industry | ||||
|---|---|---|---|---|---|
| 1 | UNHUnitedhealth | 6.5% | 26.12 | $368.81B | Managed Care |
| 2 | MCKMckesson | 8.8% | 25.61 | $117.60B | Drug Distribution |
| 3 | VEEVVeeva Systems | 16.5% | 50.85 | $51.60B | Healthcare IT |
| 4 | IQVIqvia Holdings | 8.2% | 33.17 | $45.60B | Contract Research |
| 5 | ROPRoper Technologies | 10.9% | 17.56 | $43.97B | ERP Software |
| 6 | RMDResmed | 9.9% | 24.08 | $36.68B | Medical Devices |
| 7 | GEHCGE HealthCare Technologies | 6.5% | 16.36 | $32.47B | Diagnostic Equipment |
| 8 | SSNCSS&C Technologies Holdings | 8.6% | 22.75 | $19.66B | Business Process Automation |
| 9 | RVTYRevvity | 4.1% | 75.27 | $17.88B | Life Sciences Tools |
| 10 | SOLVSolventum | -0.9% | 10.38 | $14.89B | Medical Devices |
| 11 | DVADavita | 6.4% | 14.06 | $11.92B | Healthcare Services |
| 12 | QGENQiagen | 3.0% | 26.73 | $10.94B | Life Sciences Tools |
| 13 | ALGNAlign Technology | 4.4% | 26.23 | $10.85B | Dental |
| 14 | HSICHenry Schein | 6.5% | 23.77 | $9.58B | Drug Distribution |
| 15 | OSCROscar Health | 42.8% | 16.86 | $9.29B | Managed Care |
| 16 | CAICaris Life Sciences | 85.4%OUT | 87.24 | $9.17B | Diagnostic Labs |
| 17 | HNGEHinge Health | 49.8% | 81.78 | $8.78B | Telehealth |
| 18 | NICENice | 22.9% | 8.01 | $7.65B | Communications Platforms |
| 19 | EXLSExlService Holdings | 13.6% | 25.31 | $6.33B | IT Services |
| 20 | DOCSDoximity | 11.2% | 35.96 | $6.01B | Healthcare IT |
| 21 | WAYWaystar Holding | 19.2% | 40.63 | $5.48B | Healthcare IT |
| 22 | HAEHaemonetics | 0.4% | 55.59 | $5.35B | Medical Devices |
| 23 | CCCCCC Intelligent Solutions Holdings | 11.6% | 103.78 | $4.40B | Healthcare IT |
| 24 | CDNACareDx | 34.4% | 31.81 | $3.53B | Diagnostic Labs |
| 25 | HURNHuron Consulting | 13.4% | 27.95 | $3.23B | Consulting |
| 26 | PRVAPrivia Health | 24.1% | 98.93 | $2.78B | Healthcare Services |
| 27 | FLYWFlywire | 32.2% | 68.04 | $2.32B | Payment Processing |
| 28 | PGNYProgyny | 5.5% | 28.08 | $2.21B | Healthcare Services |
| 29 | INODInnodata | 39.0% | 43.62 | $2.03B | IT Services |
| 30 | EVCMEverCommerce | 4.2% | 50.62 | $1.72B | Healthcare IT |
| 31 | OMCLOmnicell | 8.5% | 43.56 | $1.70B | Medical Devices |
| 32 | GDRXGoodRx Holdings | -1.8% | 73.60 | $1.20B | Healthcare IT |
| 33 | HSTMHealthstream | 8.8% | 47.71 | $1.01B | Healthcare IT |
| 34 | AFYAAfya | 71.8%OUT | 4.10 | $927.38M | Education Services |
| 35 | PAYSPaysign | 46.8% | 50.38 | $794.67M | Payment Processing |
| 36 | PHRPhreesia | 12.9% | 74.69 | $780.29M | Healthcare IT |
| 37 | CCSIConsensus Cloud Solutions | 1.5% | 7.28 | $688.88M | Communications Platforms |
| 38 | MTLSMaterialise | 10.2% | 33.40 | $513.88M | Business Process Automation |
| 39 | NRCNrc Health | -0.3% | 84.35 | $492.45M | Healthcare IT |
| 40 | HBBHamilton Beach Brands Holding | -3.3% | 7.80 | $447.80M | Home Appliances |
| 41 | SLPSimulations Plus | 2.1% | 46.13 | $374.00M | Healthcare IT |
| 42 | SPOKSpok Holdings | -3.4% | 17.33 | $212.13M | Healthcare IT |
| 43 | OPRXOptimizeRx | -5.8% | 36.73 | $168.98M | Healthcare IT |
| 44 | CCLDCareCloud | 15.1% | 24.80 | $73.30M | Healthcare IT |
| 45 | RSSSResearch Solutions | -1.5% | 22.08 | $62.31M | Healthcare IT |
| 46 | VASOVaso | 3.4% | 20.43 | $51.04M | Medical Devices |
| 47 | USAQQHSLab | 26.3% | 7.41 | $3.39M | Healthcare IT |
| 48 | CLRICleartronic | 18.0% | 14.24 | $2.29M | Communications Platforms |
| 49 | ESMCEscalon Medical | 5.7% | 0.67 | $1.26M | Medical Devices |
Among Healthcare IT stocks, the largest companies growing revenue faster than the median (8.8%) while trading below the median P/E (27.95) are Mckesson (MCK), Roper Technologies (ROP), Resmed (RMD), Oscar Health (OSCR) and Nice (NICE). A low multiple next to fast growth can be an opportunity or a sign the market doubts the growth will last.
The largest companies with a P/E above the median and revenue growth below it are Iqvia Holdings (IQV), Revvity (RVTY), Haemonetics (HAE), Progyny (PGNY) and EverCommerce (EVCM).
The median P/E across the 49 Healthcare IT stocks plotted is 27.95, with the middle half between 17.56 and 50.38.
The median is 8.8%, with the middle half between 4.1% and 18.0%.
The rank correlation (Spearman) is 0.14, a weak positive relationship: companies with a higher Revenue Growth (1y) (TTM) tend to have a higher P/E.
A company whose value lies more than three interquartile ranges beyond the first or third quartile is treated as an outlier. By default it stays on the chart, pinned to the edge as an open marker, and its true value is shown in the tooltip and the table. In this view 2 companies are outliers on Revenue Growth (1y) (TTM) and 0 on P/E. You can switch to percentile clamping, exclude outliers, or plot raw values on a log scale.
Metrics from Business Quant's screener: trailing-twelve-month figures from SEC filings and multiples on the latest close. A company appears once even when it lists more than one share class. A company with a secondary business line in this industry is included unless you choose primary industry only. Nothing on this page is investment advice.